{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T08:46:42Z","timestamp":1753519602303},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00120-015-3796-1","type":"journal-article","created":{"date-parts":[[2015,5,18]],"date-time":"2015-05-18T08:47:07Z","timestamp":1431938827000},"page":"641-647","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Konservative Therapie der Induratio penis plastica \u2013 Update 2015"],"prefix":"10.1007","volume":"54","author":[{"given":"G.","family":"Hatzichristodoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,15]]},"reference":[{"key":"3796_CR1","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/j.1743-6109.2011.02217.x","volume":"8","author":"Chung","year":"2011","unstructured":"Chung E, Deyoung L (2011) The role of PDE5 inhibitors in penile septal scar remodeling: assessment of clinical and radiological outcomes. J Sex Med 8:1472\u20131477","journal-title":"J Sex Med"},{"key":"3796_CR2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0022-5347(17)62993-8","volume":"97","author":"Desanctis","year":"1967","unstructured":"Desanctis P, Furey CA Jr (1967) Steroid injection therapy for Peyronie disease: a 10-year summary and review of 38 cases. J Urol 97:114\u2013116","journal-title":"J Urol"},{"key":"3796_CR3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1464-410X.2006.05955.x","volume":"97","author":"Ferrini","year":"2006","unstructured":"Ferrini M, Kovanecz I, Gaby N et al (2006) Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie\u2019s disease. BJU Int 97:625\u2013633","journal-title":"BJU Int"},{"key":"3796_CR4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/niox.2001.0421","volume":"6","author":"Ferrini","year":"2002","unstructured":"Ferrini M, Vernet D, Magee TR et al (2002) Antifibrotic role of inducible nitric oxide synthase. Nitric Oxide 6:283\u2013294","journal-title":"Nitric Oxide"},{"key":"3796_CR5","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.juro.2006.10.065","volume":"177","author":"Greenfield","year":"2007","unstructured":"Greenfield J, Shah SJ, Levine LA (2007) Verapamil versus saline in electromotive drug administration for Peyronie disease: a double-blind, placebo controlled trial. J Urol 177:972\u2013975","journal-title":"J Urol"},{"key":"3796_CR6","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/jsm.12107","volume":"10","author":"Hatzichristodoulou","year":"2013","unstructured":"Hatzichristodoulou G, Dorstewitz A, Gschwend JE et al (2013) Surgical management of penile fracture and long-term outcome on erectile function and voiding. J Sex Med 10:1424\u20131430","journal-title":"J Sex Med"},{"key":"3796_CR7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/ijir.2013.7","volume":"25","author":"Hatzichristodoulou","year":"2013","unstructured":"Hatzichristodoulou G, Gschwend JE, Lahme S (2013) Surgical therapy of Peyronie\u2019s disease by partial plaque excision and grafting with collagen fleece: feasibility study of a new technique. Int J Impot Res 25:183\u2013187","journal-title":"Int J Impot Res"},{"key":"3796_CR8","doi-asserted-by":"crossref","unstructured":"Hatzichristodoulou G, Lahme S (2014) Peyronie\u2019s disease. In: Merseburger AS, Kuczyk MM, Moul JW (Hrsg) Urology at a Glance. Springer Publishing, Berlin, S\u00a0234","DOI":"10.1007\/978-3-642-54859-8_44"},{"key":"3796_CR9","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1111\/jsm.12275","volume":"10","author":"Hatzichristodoulou","year":"2013","unstructured":"Hatzichristodoulou G, Meisner C, Gschwend JE et al (2013) Extracorporeal shock wave therapy in Peyronie\u2019s disease: results of a placebo-controlled, prospective, randomized, single-blind study. J Sex Med 10:2815\u20132821","journal-title":"J Sex Med"},{"key":"3796_CR10","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.juro.2013.01.090","volume":"190","author":"Hellstrom","year":"2013","unstructured":"Hellstrom W, Feldman R, Rosen RC et al (2013) Bother and distress associated with Peyronie\u2019s disease: validation of the Peyronie\u2019s disease questionnaire. J Urol 190:627\u2013634","journal-title":"J Urol"},{"key":"3796_CR11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0022-5347(06)00517-9","volume":"176","author":"Hellstrom","year":"2006","unstructured":"Hellstrom W, Kendirci M, Mateern R et al (2006) Single-blind, multicenter, placebo controlled, parellel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie disease. J Urol 176:394\u2013398","journal-title":"J Urol"},{"key":"3796_CR12","doi-asserted-by":"crossref","unstructured":"Kueronya V, Miernik A, Stupar S et al (2013) International multicenter psychometric evaluation of patient reported outcome data for the treatment of Peyronie\u2019s disease. BJU Int. doi:10.1111\/bju.12968","DOI":"10.1111\/bju.12968"},{"key":"3796_CR13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1743-6109.2012.03003.x","volume":"10","author":"Levine","year":"2013","unstructured":"Levine LA, Burnett A (2013) Standard operating procedures for Peyronie\u2019s disease. J Sex Med 10:230\u2013244","journal-title":"J Sex Med"},{"key":"3796_CR14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/jsm.12731","volume":"12","author":"Levine","year":"2015","unstructured":"Levine LA, Cuzin B, Mark S et al (2015) Clinical safety and effectiveness of Collagenase Clostridium Histolyticum injection on patients with Peyronie\u2019s disease: a phase 3 open-label study. J Sex Med 12:248\u2013258","journal-title":"J Sex Med"},{"key":"3796_CR15","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/j.1743-6109.2008.00814.x","volume":"5","author":"Levine","year":"2008","unstructured":"Levine LA, Newell M, Taylor F (2008) Penile traction therapy for treatment of Peyronie\u2019s disease: a single-center pilot study. J Sex Med 5:1468\u20131473","journal-title":"J Sex Med"},{"key":"3796_CR16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.2047-2927.2012.00018.x","volume":"1","author":"Mehrsai","year":"2013","unstructured":"Mehrsai A, Namdari F, Salavati A et al (2013) Comparison of transdermal electromotive administration of verapamil and dexamethason versus intra-lesional injection for Peyronie\u2019s disease. Andrology 1:129\u2013132","journal-title":"Andrology"},{"key":"3796_CR17","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/j.1743-6109.2012.02677.x","volume":"9","author":"Mulhall","year":"2012","unstructured":"Mulhall JP, Hall M, Broderick GA, Incrocci L (2012) Radiation therapy in Peyronie\u2019s disease. J Sex Med 9:1435\u20131441","journal-title":"J Sex Med"},{"key":"3796_CR18","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0022-5347(06)00270-9","volume":"175","author":"Mulhall","year":"2006","unstructured":"Mulhall JP, Schiff J, Guhring P (2006) An analysis of the natural history of Peyronie\u2019s disease. J Urol 175:2115\u20132118","journal-title":"J Urol"},{"key":"3796_CR19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.2047-2927.2012.00007.x","volume":"1","author":"Paulis","year":"2013","unstructured":"Paulis G, Brancato T, D\u2019Ascenzo R et al (2013) Efficacy of vitamin E in the conservative treatment of Peyronie\u2019s disease: legend or reality? A controlled study of 70 cases. Andrology 1:120\u2013128","journal-title":"Andrology"},{"key":"3796_CR20","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/j.1743-6109.2010.01781.x","volume":"7","author":"Ralph","year":"2010","unstructured":"Ralph D, Gonzalez-Cadavid N, Mirone V et al (2010) The management of Peyronie\u2019s disease: evidence-based 2010 guidelines. J Sex Med 7:2359\u20132374","journal-title":"J Sex Med"},{"key":"3796_CR21","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.eururo.2006.10.042","volume":"51","author":"Russell","year":"2007","unstructured":"Russell S, Steers W, Mcvary KT (2007) Systematic evidence-based analysis of plaque injection therapy for Peyronie\u2019s disease. Eur Urol 51:640\u2013647","journal-title":"Eur Urol"},{"key":"3796_CR22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/sj.ijir.3901185","volume":"16","author":"Safarinejad","year":"2004","unstructured":"Safarinejad M (2004) Therapeutic effects of colchicine in the management of Peyronie\u2019s disease: a randomized double-blind, placebo-controlled study. Int J Impot Res 16:238\u2013243","journal-title":"Int J Impot Res"},{"key":"3796_CR23","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1464-410X.2009.09041.x","volume":"106","author":"Safarinejad","year":"2009","unstructured":"Safarinejad M, Asgari MA, Hosseini Y, Dadkhah F (2009) A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie\u2019s disease. BJU Int 106:240\u2013248","journal-title":"BJU Int"},{"key":"3796_CR24","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.juro.2007.05.162","volume":"178","author":"Safarinejad","year":"2007","unstructured":"Safarinejad M, Hosseini SY, Kolahi A (2007) Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie\u2019s disease: a double-blind, pacebo controlled, randomized study. J Urol 178:1398\u20131403","journal-title":"J Urol"},{"key":"3796_CR25","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1743-6109.2007.00674.x","volume":"5","author":"Shindel","year":"2008","unstructured":"Shindel A, Bullock T, Brandes S (2008) Urologist practice patterns in the management of Peyronie\u2019s disease: a national wide survey. J Sex Med 5:954\u2013964","journal-title":"J Sex Med"},{"key":"3796_CR26","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11255-009-9522-4","volume":"41","author":"Shirazi","year":"2009","unstructured":"Shirazi M, Haghpanah AR, Badiee M et al (2009) Effect of intralesional verapamil for treatment of Peyronie\u2019s disease: a randomized single-blind, placebocontrolled study. Int Urol Nephrol 41:467\u2013471","journal-title":"Int Urol Nephrol"},{"key":"3796_CR27","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1743-6109.2011.02502.x","volume":"9","author":"Tal","year":"2012","unstructured":"Tal R, Hall MS, Alex B et al (2012) Peyronie\u2019s disease in teenagers. J Sex Med 9:302\u2013308","journal-title":"J Sex Med"},{"key":"3796_CR28","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0022-5347(05)68087-1","volume":"162","author":"Teloken","year":"1999","unstructured":"Teloken C, Rhoden El, Grazziotin TM et al (1999) Tamoxifen versus placebo in the treatment of Peyronie\u2019s disease. J Urol 162:2003\u20132005","journal-title":"J Urol"},{"key":"3796_CR29","unstructured":"Wespes E, Hatzimouratidis K, Eardley I et al (2014) Guidelines on penile curvature. European Association of Urology \u2013 online Guidelines. http:\/\/www.uroweb.org, as of February 2012:1\u201310"},{"key":"3796_CR30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1017\/S0266462300161173","volume":"16","author":"Wild","year":"2000","unstructured":"Wild C, Khene M, Wanke S (2000) Extracorporeal shock wave therapy in orthopedics. Assessment of an emerging health technology. Int J Technol Assess Health Care 16:199\u2013209","journal-title":"Int J Technol Assess Health Care"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-015-3796-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-015-3796-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-015-3796-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T06:53:37Z","timestamp":1566716017000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-015-3796-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["3796"],"URL":"https:\/\/doi.org\/10.1007\/s00120-015-3796-1","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}